HOME > Investors > Press Releases
2008-10-27
Korean Company, ViroMed Co., Ltd. Completes First Clinical Trial in the US
2008-09-10
Spotlight on ViroMed’s CAD Gene-Therapeutic VM202 in the 1st page of the Prestigious Medical Journal Radiology
2008-08-29
Final Cohort of ViroMed’s US Phase I Clinical Trial Set to Begin
2008-07-25
Cobra BioManufacturing and ViroMed Co., Ltd. Extend Collaboration and Intend to Form an R&D and Commercial Supply JV
2008-06-30
China approves Viromed`s VM202 clinical trial for Peripheral Artery Disease
11 12 13 14 15 16 17 18 19